Comparative performance of two point-of-care analysers for lipid testing

Clinical Laboratory

Volumn 53, Issue 9-10, 2007, Pages 561-566

  Shephard, Mark D S ^a   Mazzachi, Beryl C ^a   Shephard, Anne K ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Accuracy and precision; Cardiovascular disease; Lipids; Point of care testing; Total analytical error

Indexed keywords

ANALYSIS OF VARIANCE; ANALYTICAL ERROR; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD CHEMICAL ANALYSIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 38649095980     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. National Heart Foundation of Australia and The Cardiac Society of Australia and New Zealand. Lipid management guidelines 2001. Med J Aust 2001;175 Suppl:S57-85.
2. Dunstan D, Zimmet P, Wellborn T et al. Diabesity and associated disorders in Australia 2000. The accelerating epidemic. Melbourne: International Diabetes Institute, 2001.
3. Walsh W, Ring I, Brown A, Boyden A, Couzos S. Ischaemic heart disease. In: Couzos S, Murray R (eds) Aboriginal Primary Health Care. An Evidence-based Approach, 2nd ed. South Melbourne, Victoria: Oxford University Press, 2003:311-347.
4. Field P, Wakerman J, Nash K. Report on the Workshop to Review Current Research and Determine Future Research Priorities for Cardiovascular Disease in Rural and Remote Settings, and in Aboriginal and Torres Strait Islander People. Alice Springs, Northern Territory: National Heart Foundation and Centre for Remote Health, 2000.
5. Shephard M, Tallis G. Assessment of the point-of-care Cholestech lipid analyser for lipid screening in Aboriginal communities. Aust J Med Science 2002;23:4-10.
6. Warnick GR, Myers GL, Cooper GR, Rifai N. Impact of the third cholesterol report from the Adult Treatment panel of the National Cholesterol Education Program on the Clinical Laboratory. Clin Chem 2002;48:11-17.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
8. Fraser C. Biological Variation: From Principles to Practice. Washington DC, USA: American Association of Clinical Chemistry Press, 2001.
9. Shephard MDS, Gill JP. The analytical quality of point-of-care testing in the 'QAAMS' model for diabetes management in Australian Aboriginal medical services. Clin Biochem Revs 2006;27:185-190.
10. Shephard M. Clinical and cultural effectiveness of the 'QAAMS' point-of-care testing model for diabetes management in Australian Aboriginal medical services. Clin Biochem Revs 2006;27:161-170.
11. Medical Services Advisory Committee. Evaluation of near patient cholesterol testing using the Cholestech LDX. August 2001. Assessment report. Canberra, Australian Capital Territory: Commonwealth of Australia, 2002.
12. Miller WG, Waymack PP, Anderson FP, Ethridge SF, Jayne EC. Performance of four homogeneous direct methods for LDL-cholesterol. Clin Chem 2002;48:489-498.